Person

John F. Milligan

Formerly President and CEO · Director, Gilead Sciences

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$75.9M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Nov 13, 2017GILDSale220,000$72.88$16.0M
Sep 6, 2016GILDSale70,000$77.74$5.4M
Aug 1, 2016GILDSale70,000$70.94$5.0M
Jul 5, 2016GILDSale103,370$84.28$8.7M
Jul 5, 2016GILDSale8,630$84.97$733K
Jun 6, 2016GILDSale52,819$86.57$4.6M
Jun 6, 2016GILDSale59,181$87.26$5.2M
May 2, 2016GILDSale54,671$87.27$4.8M
May 2, 2016GILDSale57,329$88.14$5.1M
Apr 4, 2016GILDSale15,836$94.88$1.5M
Apr 4, 2016GILDSale96,164$94.54$9.1M
Mar 1, 2016GILDSale112,000$87.79$9.8M

SEC reporting-owner ID (CIK) 1191589 · all filings on EDGAR